Agoracom Blog Home

Posts Tagged ‘tsx’

Else Nutrition $BABY.ca Launches World’s First Globally Patented, Plant-Based Toddler Nutrition Formula on #Amazon.com $AMZN $KMB $BMY $ABT $WYE

Posted by AGORACOM-JC at 7:09 AM on Thursday, September 24th, 2020
http://blog.agoracom.com/wp-content/uploads/2020/03/else-square-150x150.png
  • Amazon to begin online sales of Else Soy free Plant-Based Toddler Nutrition in the U.S.
  • Expanding into the world’s largest online retailer as consumers continue to eat more meals at home and increasingly rely on grocery delivery services, during the COVID-19 pandemic
  • Amazon saw online grocery sales triple year-over-year during the second quarter of 2020, as more customers continue to get their groceries delivered rather than going to a physical store
  • Selling direct to consumers through online channels, is a major pillar of Else’s global go-to-market strategy
  • Furthermore, the Company’s Amazon store will provide a convenient alternative for parents who prefer shopping online.

VANCOUVER, BC / September 24, 2020 / ELSE NUTRITION HOLDINGS INC. (TSXV:BABY)(OTCQX:BABYF)(FSE:0YL) (“Else” or the “Company“), is pleased to announce that its novel, first of its kind plant-based soy free Complete & clean label Nutrition for Toddlers is now available for U.S customers via Amazon.com.

Else is expanding into the world’s largest online retailer as consumers continue to eat more meals at home and increasingly rely on grocery delivery services, during the COVID-19 pandemic. Amazon saw online grocery sales triple year-over-year during the second quarter of 2020, as more customers continue to get their groceries delivered rather than going to a physical store.

Selling direct to consumers through online channels, is a major pillar of Else’s global go-to-market strategy. Furthermore, the Company’s Amazon store will provide a convenient alternative for parents who prefer shopping online.

In addition to its own e-store and the new the Amazon.com store, the Company is aggressively pursuing new channels to bring its novel products to natural food and grocery store aisles and store shelves across the United States. Grocers are eager to satisfy consumer’s growing demand for natural, clean, non-dairy and healthy alternative product offerings in the Company’s product category. This is further amplified given the massive growth and demand they are currently experiencing as a result of stay at home orders and restaurant closures.

As a result of both a consumer demand – plant-based products continue to significantly outpace overall food sales in the U.S., fueling a significant growth opportunity for retailers.

“We’re thrilled to offer Else Nutrition’s products US nation wide on Amazon.com,” said Mrs. Hamutal Yitzhak, CEO and Co-Founder of Else. “With the launch of our plant-based Toddler complete nutrition, we’ve been getting many requests from customers who want to purchase our product on Amazon.com. This is a tremendous convenience and accessibility boost using the world’s largest e-commerce platform – as we continue our singular focus to bring novel, plant-based, clean nutrition to families,” she added.

Else Nutrition’s Plant-Based Complete Nutrition for Toddlers & Babies (12+ mo.) is now available on Amazon.com as both single (for US$36) and 4-pack (for US$136).

Canadian consumers can order Else’s products at www.elsenutrition.com.

To visit Else’s Amazon please see: https://www.amazon.com/dp/B08FM4NRMR/ref=cm_sw_r_wa_api_fab_ZBGAFb01N25NV

Else is pleased to announce that as of September 14, 2020, it retained Winning Media LLC (“Winning Media“) for digital marketing and advertising services. Winning Media will be engaged on a month to month term and will be compensated a total of USD$75,000 for its current scope of services. Neither Winning Media nor Else currently own securities in each other. The engagement is subject to approval from the TSX Venture Exchange.

About Else Nutrition Holdings Inc.

Else Nutrition GH Ltd. is an Israel-based food and nutrition company focused on developing innovative, clean and plant-based food and nutrition products for infants, toddlers, children, and adults. Its revolutionary, plant-based, non-soy, formula is a clean-ingredient alternative to dairy-based formula. Else Nutrition (formerly INDI) won the “2017 Best Health and Diet Solutions” award at the Global Food Innovation Summit in Milan. The holding company, Else Nutrition Holdings Inc, is a publicly traded company, listed as TSX Venture Exchange under the trading symbol BABY and is quoted on the US OTC Markets QX board under the trading symbol BABYF and on the Frankfurt Exchange under the symbol 0YL. Else’s Executives includes leaders hailing from leading infant nutrition companies. Many of Else advisory board members had past executive roles in companies such as Mead Johnson, Abbott Nutrition, Plum Organics and leading infant nutrition Societies, and some of them currently serve in different roles in leading medical centers and academic institutes such as Boston Children’s Hospital, Pediatrics at Harvard Medical School, USA, Tel Aviv University, Schneider Children’s Medical Center of Israel, Rambam Medical Center and Technion, Israel and University Hospital Brussels, Belgium.

For more information, visit: elsenutrition.com or @elsenutrition on Facebook and Instagram.

Media Contact:

Covet Consumer Business Unit
Gianna Totaro
[email protected]
P: 1-301-875-6574

Ms. Hamutal Yitzhak, CEO, Co-Founder & Director
ELSE Nutrition Holdings Inc.
E: [email protected]
P: +972(0)3-6445095

Mr. Sokhie Puar, Director
ELSE Nutrition Holdings Inc.
E: [email protected]
P: 604-603-7787

TSX Venture Exchange

Neither the TSX Venture Exchange nor its regulation services provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Caution Regarding Forward-Looking Statements

This press release contains statements that may constitute “forward-looking statements” within the meaning of applicable securities legislation. Forward-looking statements are typically identified by words such as “will”, “expect” or similar expressions. Forward-looking statements in this press release include statements with respect to the anticipated dates for filing the Company’s financial disclosure documents. Such forward-looking statements reflect current estimates, beliefs and assumptions, which are based on management’s perception of current conditions and expected future developments, as well as other factors management believes are appropriate in the circumstances. No assurance can be given that the foregoing will prove to be correct. Forward-looking statements made in this press release assume, among others, the expectation that listing on the FSE will create additional liquidity and attract additional investors in the European market. Actual results may differ from the estimates, beliefs and assumptions expressed or implied in the forward-looking statements. Readers are cautioned not to place undue reliance on any forward-looking statements, which reflect management’s expectations only as of the date of this press release. The Company disclaims any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

SOURCE: Else Nutrition Holdings

Spyder #Cannabis $SPDR.ca Announces Opening of Calgary Cannabis Dispensary $CGC.ca $TLRY $APHA.ca

Posted by AGORACOM-JC at 3:32 PM on Wednesday, September 23rd, 2020
  • Announced that its Calgary Cannabis dispensary located at 140-104 58 Avenue SE, will be open for business effective Saturday, September 26, 2020
  • “The Spyder team is excited to commence operations at its second location and bring its best of class customer service and retail experience to one of Calgary’s busiest commercial hubs,” stated Dan Pelchovitz, the company’s CEO.
  • Company is also currently looking at several additional locations in both Alberta and Ontario where it intends to expand the Spyder Cannabis brand’s footprint

Vaughan, Ontario–(September 23, 2020) – Spyder Cannabis Inc. (TSXV: SPDR) (“Spyder” or the “Company”) and its wholly-owned associated applicants, The Green Spyder Inc. and Spyder Cannabis Subco Inc., is pleased to announce that its Calgary Cannabis dispensary located at 140-104 58 Avenue SE, will be open for business effective Saturday, September 26, 2020.

“The Spyder team is excited to commence operations at its second location and bring its best of class customer service and retail experience to one of Calgary’s busiest commercial hubs,” stated Dan Pelchovitz, the company’s CEO.

The company is also currently looking at several additional locations in both Alberta and Ontario where it intends to expand the Spyder Cannabis brand’s footprint.

About Spyder Cannabis Inc.

Spyder is a Cannabis, Vape and CBD retailer that operates in jurisdictions where the products are federally legal in both Canada and the United States. The Company, through its subsidiaries, is a retailer involved in the development of three retail business units. The first is the sale of Cannabis products, the second is the sale of Hemp CBD in the United States only, the third is the sale of smoking cessation products in Ontario.

For more information, please contact:
Dan Pelchovitz
905-265-8273

Cautionary Statements

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

This news release includes statements containing certain ‘forward-looking information” within the meaning of applicable securities laws (‘forward-looking statements”). Forward-looking statements are frequently characterized by words such as “plan”, “continue”, “expect”, “project”, “intend”, “believe”, “anticipate”, “estimate”, “may”, “will”, “potential”, “proposed” and other similar words, or statements that certain events or conditions “may” or “will” occur.

KWESST $KWE.ca Completes First Phase of Contract Delivery For TASCS to U.S. Military Customer $WRTC $BYRN.ca $PAT.ca $POWW

Posted by AGORACOM-JC at 8:32 AM on Tuesday, September 22nd, 2020
  • Announced the successful completion of the first phase of three deliverables under a contract to support a U.S. military customer featuring the Company’s signature Tactical Awareness and Situational Control System” (“TASCS”)
  • First deliverable under a $500,000 (CAD) contract demonstrated the TASCS Integrated Fires Module on mortars and the Augmented Weapon Sight, a system developed by AeroVironment Inc. and KWESST to provide real-time situational awareness and targeting information
  • “These important military exercises demonstrate the maturity of the TASCS system,” said KWESST CEO Jeff MacLeod

Ottawa, Ontario–(September 22, 2020) – KWESST Micro Systems Inc. (TSXV: KWE) (“KWESST” or “the Company”) today announced the successful completion of the first phase of three deliverables under a contract to support a U.S. military customer featuring the Company’s signature Tactical Awareness and Situational Control System” (“TASCS”).

This first deliverable under a $500,000 (CAD) contract demonstrated the TASCS Integrated Fires Module (“IFM”) on mortars and the Augmented Weapon Sight (“AWS”), a system developed by AeroVironment Inc. (“AeroVironment”) and KWESST to provide real-time situational awareness and targeting information. AWS streams Full Motion Video (“FMV”) from an overhead Unmanned Aerial Vehicle (“UAV” or “drone”) manufactured by AeroVironment into the TASCS architecture for the purpose of target identification, accurate first-shot hits and real-time Battle Damage Assessment (“BDA”). The AWS system has been an ongoing collaboration between KWESST and AeroVironment.

“These important military exercises demonstrate the maturity of the TASCS system,” said KWESST CEO Jeff MacLeod. “We are very pleased at the performance of the system and the valuable user feedback. We expect the next two contracted demonstration exercises later this year to attract added customer attention and the development of operating procedures that will be employed in more extensive exercises expected in early 2021.”

David Luxton, Executive Chairman, added, “Demonstration exercises like this with military customers are an important phase in the process towards potential introduction into service. It is very encouraging that this key U.S. military customer is scheduling additional exercises, and that at least two other NATO military customers have similar capability demonstration contracts under consideration.”

About TASCS, IFM and AWS

“TASCS” is an app and snap-on weapon adaptor that streams situational awareness and targeting information from any source directly to soldiers’ smart devices and their weapons systems for a leap ahead in safer and more effective engagement of adversaries. “IFM” is the variant of TASCS that integrates this capability into many short-range and long-range weapons systems, including grenade launchers and mortars. “AWS” utilizes the TASCS system to stream situational and targeting information from AeroVironment Unmanned Aerial Vehicles (“UAV”s, or “drones”) directly to the TASCS display on soldiers’ smart devices and weapons systems in real time.

About KWESST

KWESST develops and commercializes high-value ultra-miniaturized technology applications that make a critical difference to the safety and operational effectiveness of personnel in the defence and security industries. The company’s current portfolio of unique proprietary offerings include: its signature TASCSTM (Tactical and Situational Control System) for real-time awareness and targeting information from any source (including drones) streamed directly to users’ smart devices and weapons; the autonomous Grey GhostTM soldier-portable micro drone missile system that defends against small hostile drones including swarms using high-speed kinetic impact; a Ground Laser Defence system to counter the emerging threat of weaponized lasers against personnel; and, the PhantomTM electronic battlefield decoy system to mask the electromagnetic signature of friendly forces with decoy signatures at false locations to deceive and confuse adversaries. All systems can operate stand-alone or integrate seamlessly with OEM products and battlefield management systems including Frontline, Edge, Killswitch and ATAK (Android Tactical Assault Kit) among others. KWESST also has developmental “smart ordnance” projects including its “Shot Counter” system, which records the number and type of rounds fired, for optimized firearms maintenance and performance. The Company is headquartered in Ottawa, Canada, with representative offices in Washington, DC, London, UK and Abu Dhabi, UAE and trades on the TSXV under the symbol KWE.

Contact: Jason Frame, Investor Relations
Email: [email protected]
For more information please visit www.kwesst.com

Cautionary Note Regarding Forward-Looking Statements

This news release includes certain “forward-looking statements” under applicable Canadian securities legislation. Forward-looking statements include, but are not limited to, statements with respect to the timing for the commencement of trading and the plans and operations of KWESST after giving effect to the Qualifying Transaction. Forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties and other factors which may cause the actual results and future events to differ materially from those expressed or implied by such forward-looking statements. Such factors include, but are not limited to: general business, economic, competitive, political and social uncertainties. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements. KWESST disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this news release.

Red Light Holland $TRIP.ca Grants Exclusive Access to a Prominent Canadian Production Company and Film Crew to Document the Company in the Netherlands $IPO $SHRM.ca $RVV.ca $CMPS $MMED

Posted by AGORACOM at 10:04 AM on Monday, September 21st, 2020
https://s3.amazonaws.com/s3.agoracom.com/public/companies/logos/564679/hub/Red_Light_Holland_Logo_2.png

Toronto, Ontario–(Newsfile Corp. – September 21, 2020) – Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (“Red Light Holland” or the “Company“), an Ontario-based corporation positioning itself to engage in the production, growth and sale of its brand of magic truffles to the legal, recreational market within the Netherlands, is pleased to announce that it has granted a prominent Canadian production company and film crew exclusive access to provide video coverage of the activities of the Company and its Chief Executive Officer, Todd Shapiro, within the Netherlands, leading up to the Company’s previously announced iMicrodose product launch party (the “iMicrodose Launch Party“), scheduled on September 25, 2020, in Amsterdam, the Netherlands. Filming commenced on September 20, 2020 in Horst, the Netherlands (the location of the Company’s production and distribution facility) and will continue through to the iMicrodose Launch Party, covering, among other things, the iMicrodose brand, and the production and distribution facility.

“I’m so grateful for this production company reaching out and offering to document our journey. There’s a ton of hard work that is going on behind the scenes and if all goes according to plan – this will be another piece of earned Media, which hasn’t cost Red Light Holland a dime, to potentially highlight our Company, our tireless efforts and our iMicrodose brand to a much bigger widespread audience,” said Chief Executive Officer and Director of the Company, Todd Shapiro. “Out of respect to the production company’s intellectual property rights, which play a huge role in stimulating innovation and creativity – in this case focusing on Red Light Holland’s early magic truffles production facility, our iMicrodose product launch in the Netherlands, and our expected iMicrodose Launch Party – we’ve mutually agreed to hold off on providing more information for now. However, we look forward to sharing more details in early 2021 about this great exposure opportunity… Now let’s just hope my mug doesn’t get left on the cutting room floor!”

About Red Light Holland Corp.

The Company is an Ontario-based corporation positioning itself to engage in the production, growth and sale (through existing Smart Shops operators and an advanced e-commerce platform) of a premium brand of magic truffles to the legal, recreational market within the Netherlands, in accordance with the highest standards, in compliance with all applicable laws.

For additional information on the Company:

Todd Shapiro
Chief Executive Officer & Director
Tel: 647-204-7129
Email: [email protected]
Website: https://redlighttruffles.com/

Vegaste Technologies Corp. $VEGA.ca launches PlantX.ca to better serve the Canadian market $BYND $TSN $CAG $FMCI $VERY $MEAT

Posted by AGORACOM-JC at 9:32 AM on Monday, September 21st, 2020
PlantX | LinkedIn
  • Company has launched its new domain www.PlantX.ca to better serve the Canadian market
  • New .ca domain will allow PlantX, the one-stop-shop for everything plant-based and the digital face of the plant-based community, to strengthen its Canadian presence and ability to offer its growing plant-based product line to Canadian consumers using its e-commerce platform

VANCOUVER,  BC, Sept. 21, 2020 – Vegaste Technologies Corp. (the ” Company ” or ” Vegaste “) (CSE: VEGA ), is pleased to announce that the Company has launched its new domain www.PlantX.ca to better serve the Canadian market.

The new .ca domain will allow PlantX, the one-stop-shop for everything plant-based and the digital face of the plant-based community, to strengthen its Canadian presence and ability to offer its growing plant-based product line to Canadian consumers using its e-commerce platform.

The new domain www.PlantX.ca will feature a growing list of partnerships with Canadian companies including Vita Life Fresh Market and UpMeals to offer plant-based vitamins, supplements, groceries, PlantX-branded water and plant-based meals made by LA-based chef Gregg Drusinsky . In addition to its e-commerce functionality, the site will offer Canadian consumers weekly updated plant-based recipes, restaurant resources and connects like-minded users in a community forum.

“Having a “.ca” domain is very exciting for us as a Canadian-based company,” said Sean Dollinger , PlantX founder “We plan to use this as an example of what we can do around the world as we expand, continue making new partnerships, and offer the best products and experience in every market.”

“At PlantX we’ve built our online platform with a different set of inventory, shipping logistics, payment processors, and other logistics separated by region,” says Alexandra Hoffman , PlantX Chief Marketing Officer. “Dividing the company traffic among different domains makes the company’s regional logistics systems better. I work very close with our development team, and it’s so exciting to see how quickly we can deploy sites for new locations.”

Since its inception in October, 2019, the Company’s PlantX platform has quickly emerged as an industry leader. As the fledgling plant-based sector continues its explosive growth, the Company will be at the forefront by continually evolving and delivering new ways to expand PlantX. With its forward-looking, cutting edge approach, the Company will continue to secure significant partnerships across North America while exploring innovative ways to expand both its e-commerce capabilities and digital resources to help educate, inspire, and uplift consumers.

About Vegaste

As the digital face of the plant-based community, Vegaste’s PlantX platform is the one-stop-shop for everything plant-based. With its fast growing category verticals, the Company will offer customers across North America more than 10,000 plant-based products by the end of September. In addition to offering meal and indoor plant deliveries, Vegaste currently has plans underway to expand its product lines to include cosmetics, vitamins, clothing, and its own water brand — but the business is not limited to an e-commerce platform. Vegaste uses its digital platform to build a community of like-minded consumers and most importantly, provide education. Its successful enterprise is being built and fortified on partnerships with top nutritionists, chefs, and brands. Vegaste eliminates the barriers to entry for anyone interested in living a plant-based lifestyle, and thriving in a longer, healthier, and happier life.

The Company’s lynchpin www.PlantX.com is the digital face of everything plant-based and fueled by the power of education and accessibility. For those who don’t have the time to cook their own healthy plant-based meals, Vegaste offers a wide array of pre-made meals curated by Executive Chefs and nutritionists. For those looking to learn how to cook their own plant-based meals, Vegaste offers regularly updated weekly recipes. Unlike other plant-based e-commerce companies, Vegaste has a large selection of indoor plants for sale. The site educates consumers on the benefits of a plant-based diet with a specialized blog, connects like-minded individuals with its forum, and provides resources for the best plant-based restaurants, pop-up retailers and products across Canada and the USA .

Forward-Looking Information

This press release contains “forward-looking information” within the meaning of applicable securities laws. All statements contained herein that are not clearly historical in nature may constitute forward-looking information. In some cases, forward-looking information can be identified by words or phrases such as “may”, “will”, “expect”, “likely”, “should”, “would”, “plan”, “anticipate”, “intend”, “potential”, “proposed”, “estimate”, “believe” or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions “may” or “will” happen, or by discussions of strategy. The forward-looking information contained herein includes statements regarding the business and strategic plans of the Company.

By their nature, forward-looking information is subject to inherent risks and uncertainties that may be general or specific and which give rise to the possibility that expectations, forecasts, predictions, projections or conclusions will not prove to be accurate, that assumptions may not be correct and that objectives, strategic goals and priorities will not be achieved. A variety of factors, including known and unknown risks, many of which are beyond our control, could cause actual results to differ materially from the forward-looking information in this press release including, without limitation: the Company’s ability to secure additional commercial partnerships across North America , the Company’s ability to comply with all applicable governmental regulations including all applicable food safety laws and regulations; impacts to the business and operations of the Company due to the COVID-19 epidemic; a limited operating history, the ability of the Company to access capital to meet future financing needs; the Company’s reliance on management and key personnel; competition; changes in consumer trends; foreign currency fluctuations; and general economic, market or business conditions.

Additional risk factors can also be found in the Company’s continuous disclosure documents which have been filed on SEDAR and can be accessed at www.sedar.com . Readers are cautioned to consider these and other factors, uncertainties and potential events carefully and not to put undue reliance on forward-looking information. The forward-looking information contained herein is made as of the date of this press release and is based on the beliefs, estimates, expectations and opinions of management on the date such forward-looking information is made.

The Company undertakes no obligation to update or revise any forward-looking information, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.

The Company website is http://investor.plantx.com/ .

SOURCE Vegaste Technologies Corp.

Avicanna’s $AVCN.ca RHO Phyto™ Rapid Act Sprays are Now Available Nation Wide in Canada Through Medical Cannabis by Shoppers™ $WEED.ca $CL.ca $HEXO.ca

Posted by AGORACOM-JC at 9:27 AM on Monday, September 21st, 2020
http://www.smallcapepicenter.com/Avicana%20square%20logo.jpg

Avicanna Rapid Act Spray

  • RHO Phyto™ Rapid Act Sprays are now available nationwide in high ratios of CBD to THC and are designed for rapid absorption and with lemon-mint flavour on the Medical Cannabis by Shoppers™ portal.
  • The Rapid Act Sprays are also available for the Medical Cannabis Real World Evidence Studies (MC-RWE) conducted by the University Health Network in partnerships with Medical Cannabis by Shoppers along side RHO Phyto’s Micro Drop Oil formulations.

TORONTO , Sept. 21, 2020 – Avicanna Inc. (” Avicanna ” or the ” Company “) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a biopharmaceutical company focused on the development, manufacturing and commercialization of plant-derived cannabinoid-based products, is pleased to announce that its advanced RHO Phyto Rapid Act Sprays are now officially available nationwide in Canada on the Medical Cannabis by Shoppers (” Shoppers “) portal, as well as through the Medical Cannabis Real-World Evidence Study at the University Health Network.

Avicanna’s RHO Phyto product line is now commercially available after years of research and development through collaborations with world class academic and clinical organizations. The development of RHO Phyto products has focused on the key properties in drug development that health care providers seek when recommending a medical product to their patients such as formulation stability for consistent dosing, enhanced absorption and a range of onset times.

The Rapid Act Spray is a sublingual spray and is among the second set of Avicanna’s RHO Phyto products available for purchase through Shoppers. The sublingual sprays bypass first-pass metabolism and are quickly absorbed in the mucosal lining under the tongue. The RHO Phyto Rapid Act Spray provides an alternative delivery form to the RHO Phyto Micro Drops (also available for sale through Shoppers) which are absorbed through the oral route. The RHO Phyto Rapid Act Sprays have been formulated with specific ingredients that enhance absorption and the onset time of cannabinoids across the mucous membrane beneath the tongue. The lemon-mint flavoured sprays will be available in 10:20 CBD and 2:40 (w/w) THC to CBD ratios.

Dr. Justin Grant , Avicanna’s Executive Vice President of Scientific Affairs, commented, “The RHO Phyto Rapid Act Sprays are designed for faster onset and can be used in acute conditions where patients seek faster relief. The sublingual sprays can also be used to supplement slower and longer acting products, such as the RHO Phyto Micro Drop, when occasional higher doses may be required. Sublingual administration provides an alternative to the potentially harmful effects of consuming inhalation products.”

In August 2020 , Avicanna launched its blood orange flavoured RHO Phyto Micro Drop 2:50 CBD and Micro Drop 5:20 CBD. In the coming months, Avicanna will be launching its much-anticipated RHO Phyto Deep Tissue Gel, Daily Cream and Simple Dose Capsules. To ensure batch-to-batch consistency and high-quality products, these formulations are manufactured at MediPharm Labs Inc, a Good Manufacturing Practices (” GMP “) certified facility. In addition to strict GMP manufacturing, all RHO Phyto products undergo GMP-level analytical testing by Sigma Analytical Services Inc. and use blockchain technology developed by TruTrace Technologies Inc. to manage, track and trace each step of the supply chain.

Detailed guidelines outlining dosing and titration for Health Care Practitioners (” HCPs “) and patients is available on the RHO Phyto website at www.rhophyto.com . In addition, the Avicanna Academy includes additional product information for patients, frequently asked questions, and a recording of Avicanna’s 3rd annual symposium which was hosted virtually in partnership with Shoppers on July 21, 2020. For more information visit https://www.avicanna.com/the-avicanna-academy/ .

The Company has also re-branded and re-launched its subsidiary, My Cannabis Clinic (formerly known as My Cannabis), which specializes in assisting patients to gain access to medical cannabis and cannabinoid-based products for medical use. My Cannabis Clinic is devoted to providing HCPs and patients with the support and education needed for medical cannabis use. My Cannabis Clinic believes in providing quality care to patients and providing education on the considerations and potential benefits that cannabis has to offer for medical use. Information about My Cannabis Clinic can be found at https://mycannabisclinic.org/ .

About Avicanna

Avicanna is a diversified and vertically integrated Canadian biopharmaceutical company focused on the research, development, and commercialization of plant-derived cannabinoid-based products for the global consumer, medical, and pharmaceutical market segments.

Avicanna is an established leader in cannabinoid research and development, which it primarily conducts at its R&D headquarters in the Johnson & Johnson Innovation Centre, JLABS @ Toronto, Canada and in collaboration with leading Canadian academic and medical institutions. In addition to its developing pharmaceutical pipeline, Avicanna’s team of experts have developed and commercialized several industry leading product lines, including:

  • Pura H&W™: an advanced and clinically tested line of CBD consumer derma-cosmetic products; and,
  • RHO Phyto™: an advanced line of medical cannabis products containing varying ratios of CBD and THC currently available nation-wide across Canada in partnership with Medical Cannabis by Shoppers™, a subsidiary of Shoppers Drug Mart. RHO Phyto is the first strictly medical formulary of advanced “Cannabis 2.0” products, containing oils, sprays, capsules, creams, and gels, all developed with scientific rigour, manufactured under GMP standards and supported by pre-clinical data.

With ongoing clinical trials on its derma-cosmetic (Pura H&W), medical cannabis (RHO Phyto) and a pipeline of pharmaceutical products, Avicanna’s dedication to researching the important role that cannabinoids play in an increasingly wider scope of products has been at the core of the Company’s vision since its inception. Furthermore, Avicanna’s commitment to education is demonstrated through its annual medical symposium, the Avicanna Academy educational platform, and the My Cannabis Clinic patient program through its subsidiary company.

Avicanna manages its own supply chain including cultivation and extraction through its two majority-owned subsidiaries, Sativa Nativa S.A.S. and Santa Marta Golden Hemp S.A.S., both located in Santa Marta, Colombia. Through these sustainable, economical, and industrial scale subsidiaries, Avicanna cultivates, processes, and commercializes a range of cannabis and hemp cultivars dominant in CBD, CBG, THC, and other cannabinoids for use as active pharmaceutical ingredients. Avicanna’s Avesta Genetica program specializes in the development and optimization of rare cultivars for commercial production along with feminized seeds for global export. In June 2020, Avicanna made history with a shipment of hemp seeds to the United States of America by completing the first ever export of hemp seeds from Colombia.

SOURCE Avicanna Inc.

Stay Connected

For more information about Avicanna, visit www.avicanna.com , call 1-647-243-5283, or contact Setu Purohit , President by email at [email protected] .

Cautionary Note Regarding Forward-Looking Information and Statements

This news release contains “forward-looking information” within the meaning of applicable securities laws. Forward-looking information contained in this press release may be identified by the use of words such as, “may”, “would”, “could”, “will”, “likely”, “expect”, “anticipate”, “believe, “intend”, “plan”, “forecast”, “project”, “estimate”, “outlook” and other similar expressions, and includes statements with respec t to the ability of the RHO Phyto Rapid Act Sprays to be used in acute conditions where patients seek faster relief, the ability of the RHO Phyto Rapid Act Sprays to be used to supplement slower and longer acting products, the ability of the Company launching the RHO Phyto Deep Tissue Gel, Daily Cream and Simple Dose Capsules , the ability of My Cannabis Clinic to provide HCPs and patients with the support and education needed for medical cannabis use, and that there is a benefit to using cannabis for medical purposes. Forward-looking information is not a guarantee of future performance and is based upon a number of estimates and assumptions of management in light of management’s experience and perception of trends, current conditions and expected developments, as well as other factors relevant in the circumstances, including assumptions in respect of current and future market conditions, the current and future regulatory environment; and the availability of licenses, approvals and permits.

Although the Company believes that the expectations and assumptions on which such forward-looking information is based are reasonable, undue reliance should not be placed on the forward-looking information because the Company can give no assurance that they will prove to be correct. Actual results and developments may differ materially from those contemplated by these statements. Forward-looking information is subject to a variety of risks and uncertainties that could cause actual events or results to differ materially from those projected in the forward-looking information. Such risks and uncertainties include, but are not limited to current and future market conditions, including the market price of the common shares of the Company, and the risk factors set out in the Company’s annual information form dated April 15, 2020 , filed with the Canadian securities regulators and available under the Company’s profile on SEDAR at www.sedar.com .

The statements in this press release are made as of the date of this release. The Company disclaims any intent or obligation to update any forward-looking information, whether as a result of new information, future events or results or otherwise, other than as required by applicable securities laws.

MedX Health Corp. $MDX.ca Bolsters Global Footprint and Adds Renowned Skin Care Expert to Senior Leadership Team $DMTK $ICAD $PLSE $SRTS

Posted by AGORACOM-JC at 9:16 AM on Monday, September 21st, 2020
Home - MedX Health
  • Announced the appointment of veteran healthcare industry executive Naman Demaghlatrous as Managing Director, Europe, Middle East & Africa (“EMEA”), effective immediately
  • Additionally, Chantal Ward, RN has taken a permanent position with the Company as Director, Dermatological Services

MedX Health Corp. (“MedX”) (TSX-V: MDX) is pleased to announce the appointment of veteran healthcare industry executive Naman Demaghlatrous as Managing Director, Europe, Middle East & Africa (“EMEA”), effective immediately. Additionally, Chantal Ward, RN has taken a permanent position with the Company as Director, Dermatological Services.

“Naman’s extensive background in healthcare and medical devices, along with his deep relationships will allow us to accelerate business development opportunities in the region,” said Mike Druhan, President of Dermatological Products & Services. “Chantal is an internationally recognized and respected leader in the dermatology and aesthetics spaces, bringing credibility to our offerings and putting an impressive opinion leader network at our disposal.”

Mr. Demaghlatrous has more than 20 years of experience in the healthcare industry, including roles with medical device and pharmaceutical companies leading business strategy, international product licensing, business development and operations. He has proven expertise in leading organizations through start-up to rapid growth, expansion and value creation with companies such as Medtronic, Pediapharm, Johnson & Johnson and Atfal Pharma. Mr. Demaghlatrous will play an integral part in MedX’s revenue growth prospects by securing European, Middle Eastern and African partnerships for MedX’s skin assessment telemedicine technology. Initially supporting the roll out and expansions in the Netherlands, Spain and Turkey, he will also be responsible for securing joint ventures and partnerships across the EMEA Region.

“Helping patients access an e-consult on suspicious lesions or moles quickly and easily means better treatment and better outcomes,” noted Mr. Demaghlatrous. “There is already significant interest and traction across the region and I am expecting substantial growth over the next six to nine months.”

Chantal Ward RN, a Diploma Nurse Graduate from an operating room background, has 20+ years’ experience as a clinical trainer of advanced medical aesthetic equipment and technology. Her expertise is acknowledged across Canada and around the world, where she has provided guidance and training to hundreds of medical aesthetic professionals. Ms. Ward is Co-Founder of Clarity MedSpa & Laser Centre, Toronto and has significant experience with MedX’s SIAscopy on DermSecure™.

“I have been using this device in my clinic for several years and have caught multiple melanomas,” said Ms. Ward. “The device is easy to use and the ability to have a dermatologist provide a remote e-consult, within 72 hours, is critical. Early detection is the key to a successful patient outcome.”

“MedX is in full commercialization mode and Naman and Chantal are welcomed additions to our team. Recently, Damon Goodwin and Nick Hoffman have been announced to our senior management team and we are already feeling their impact. It is a satisfying to know that MedX can attract such seasoned professionals and I strongly believe that is because of the strength of our technology offering and the culture we have built,” further commented Mr. Druhan.

Currently, between two and three million non-melanoma skin cancers and 300,000 melanoma skin cancers occur globally each year. One in every three cancers diagnosed is a skin cancer and, according to Skin Cancer Foundation statistics, one in every five people will develop skin cancer in their lifetime. The global demand for SIAscopy on DermSecure™ will continue to increase with the growth of telemedicine and as early detection is recognized as the way to optimize survival and reduce healthcare costs.

About MedX

MedX, headquartered in Mississauga, Ontario, is a leading medical device and software company focused on skin health with its SIAscopy on DermSecure™ telemedicine platform, utilizing its SIAscopy™ technology. SIAscopy is also imbedded in its products SIAMETRICS™, SIMSYS™, and MoleMate™, which MedX manufactures in its ISO 13485 certified facility. SIAMETRICS™, SIMSYS™, and MoleMate™ include hand-held devices that use patented technology utilizing light and its remittance to view up to 2 mm beneath suspicious moles and lesions in a pain free, non-invasive manner, with its software then creating real-time images for physicians and dermatologists to evaluate all types of moles or lesions within seconds. These products are Health Canada, FDA, TGA and CE cleared for use in Canada, the US, Australia, New Zealand, the European Union and Turkey. MedX also designs, manufactures and distributes quality photobiomodulation therapeutic and dental lasers to provide drug-free and non-invasive treatment of tissue damage and pain. www.medxhealth.com

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

This Media Release may contain forward-looking statements, which reflect the Company’s current expectations regarding future events. The forward-looking statements involve risks and uncertainties.

View source version on businesswire.com: https://www.businesswire.com/news/home/20200921005178/en/

Contacts:

Mike Druhan, President, Dermatological Services
MedX Health Corp
Tel: 905-599-7852

VIDEO – $HPQ.ca Silicon Development Agreement With #Apollon Solar Expands Into Producing HYDROGEN, With Samples To French Military By December $DUK $XEL $NEE $PYR.ca

Posted by AGORACOM-JC at 3:39 PM on Friday, September 18th, 2020

When a CEO puts this quote in a press release, you have to take it seriously, especially when his two technology partners helping deliver on it are world renowned:

“Since 2017, our collaboration with Apollon has enabled us to benefit from their world-renowned expertise with high value-added Silicon applications.  The addition of manufacturing hydrogen by hydrolysis to our collaboration opens up a new and unique business opportunity that could represent a second multibillion-dollar addressable market for the PUREVAPTM Nano Silicon (Si) Reactor (“NSiR”) nanopowders.

HYDROGEN BY HYDROLYSIS

Two technologies that could deliver vehicles with zero emissions are battery-electric powertrains and hydrogen fuel cells. HPQ is already on the road to becoming an electric battery player, with 2 NDA’s signed in the space – and now will be ready to start sending samples of its nano silicon powders to manufacture Hydrogen by hydrolysis, which is: 

“Getting porous silicon nano powders to react with water “H2O” and thereby releasing significant quantities of Hydrogen ” H2  “.

For decades, hydrogen was presumed to be “the fuel of the future,” with electric cars limited to the niche of small, short-range urban cars – but hasn’t been able to deliver due to too many issues to mention here with fuel cells.  Hydrogen by Hydrolysis is a great alternative but cost prohibitive due to the costs of porous silicon nano powders + power generation inefficiencies …. until now.

Enter HPQ Silicon.  

HPQ Silicon is so confident it can solve this problem that it will have samples of its powders ready for delivery to Apollon Solar and the French Military for testing by December.

Watch this interview or listen by Podcast on AppleGoogleSpotify or your favourite podcaster.

CLIENT FEATURE: Else Nutrition $BABY.ca The Award Winning, Plant-Based Nutrition Company For Small Cap Investors $KMB $BMY $ABT $WYE

Posted by AGORACOM-JC at 5:54 PM on Thursday, September 17th, 2020
http://blog.agoracom.com/wp-content/uploads/2020/03/else-square-150x150.png

(TSXV: BABY) (OTCQX: BABYF) (FSE: 0YL)

A Game Changer In Plant-Based Nutrition

Highlights

  • $CAD 18M bought deal financing + $CAD 6M private placement
  • US distribution agreement signed
  • Full-scale marketing campaign launched
  • Backed by A Billion Dollar Global Nutrition Company;
  • “Best Health” Award At Global Food Innovation Summit In Milan;
  • Awarded Patents In 22 Countries, 44 Countries Pending;
  • USDA Organic Certification and multiple other key certifications.
  • Partnership with celebrity author, podcast host and parenting expert, Hilaria Baldwin

Why Else Nutrition?

  • Gives Small Cap Investors An Opportunity To Participate In Global Paradigm Shift Towards Plant-Based, Clean Label Foods For Toddlers & Children
  • 7 Years of  R&D
  • Launched 1st Commercial Product Into US Market
  • 100% Plant-Based, Organic Toddler Nutrition Product 
  • Market Research Survey Finds Over 60% Positive Purchase Intent For Else Product
  • Fills A Market Gap In Plant-Based Toddler Nutrition (12-36 months)
  • Subsidiary Of Billion Dollar Hong Kong Listed Conglomerate (H&H) Owns Approx 11.15% Of BABY
  • H&H Right To Maintain 11.15% Ownership Through Future Financings

Watch Out Alec Baldwin, Hilaria’s Got a New Love 😉

https://youtube.com/watch?v=UBiYSt9Jekg

The Product

Else Plant-Based Toddler Nutrition

Dairy-free | Soy-free | Corn Syrup-free | Gluten-free

Hub On AGORACOM / Corporate Profile

Else Nutrition Holdings is an advertising client of AGORA Internet Relations Corp.

$HPQ.ca and Apollon Solar Extend Agreement to Work on Porous Silicon for Batteries and Expand Collaboration to Include Hydrogen Production $DUK $XEL $NEE $PYR.ca

Posted by AGORACOM-JC at 1:04 PM on Thursday, September 17th, 2020
  • Announced the extension, until December 31, 2020, of the Development Agreement signed with Apollon solar SAS in 2017
  • This fifth renewal will be focused on extremely promising venues for both the renewable energy sector and the decarbonization of the economy

MONTREAL, Sept. 17, 2020 — HPQ Silicon Resources Inc. (“HPQ” or “ Company”) TSX-V: HPQ; FWB: UGEOther OTC : URAGF; is pleased to announce the extension, until December 31, 2020, of the Development Agreement signed with Apollon solar SAS (“Apollon”) in 2017.  This fifth renewal will be focused on extremely promising venues for both the renewable energy sector and the decarbonization of the economy, mainly:

  1. Energy Storage development of a new generation of Lithium-ion batteries made using Porous Silicon manufactured by the transformation of HPQ PUREVAPTM Quartz Reduction Reactor “QRR” Silicon (Si) with Apollon patented process;

  2. Clean Renewable Hydrogen Production using Apollon Solar Gennao H2TM  200W, a fuel cell – based system that can produce hydrogen by hydrolysis simply by combining water with an environmentally friendly1 chemical powder.  Replacing the chemical powder presently used with nano silicon powders, such as those about to be produced by the HPQ NANO PUREVAPTM Nano Silicon Reactor (“NSiR”), could significantly increase the hydrogen generation capacity of the system.

“Since 2015, HPQ has been working on revolutionizing silicon manufacturing and its applications with the development of our PUREVAPTM technologies, scalable and extremely versatile processes that will allow the production of silicon materials perfectly suited to assist in the goals of decarbonization of the economy and the generation of green renewable energies” said Bernard Tourillon, President & CEO of HPQ Silicon Resources Inc.  “Since 2017, our collaboration with Apollon has enabled us to benefit from their world-renowned expertise with high value-added Silicon applications.  The addition of manufacturing hydrogen by hydrolysis to our collaboration opens up a new and unique business opportunity that could represent a second multibillion-dollar addressable market for the PUREVAPTM Nano Silicon (Si) Reactor (“NSiR”) nanopowders.”

APOLLON PROCESS: MAKING POROUS SILICON MANUFACTURING ECONOMICALLY VIABLE

Porous silicon is a Silicon (Si) structure in which Nanopores have been formed by electrochemical etching.  Addressable markets for porous silicon are substantial, but existing electrochemical etching processes require very pure Silicon (Si) feed stock (9N to 11N), making porous Silicon cost prohibitive.

To make affordable porous Silicon, Apollon developed and obtained a worldwide patent for an electrochemical etching process that can use (2N to 4N) Silicon (Si) to make porous Silicon wafers.

AIMING TO SEND POROUS SILICON NANOPOWDER SAMPLES TO END USERS BY DECEMBER 2020

Mindful of HPQ’s competitive advantage, the ability of PUREVAPTM QRR to produce 2N to 4N Silicon (Si) at the lowest cost in the industry, HPQ and Apollon are busy manufacturing samples of porous Si nanopowders of different sizes (2 nm to 1 µm) with porous structure sizes of either Microporous (<5nm), Mesoporous (5nm – 50nm) and Macroporous (>50nm).  The aim being to send samples, to end users’ specifications, by December 2020.  The extension of the agreement continues HPQ’s North American exclusivity over the use of Apollon’s patented process to manufacture Porous Silicon until at least December 31, 2020.

________________
1 Non-toxic and recyclable

HYDROLYSIS HYDROGEN PRODUCTION: APOLLON SOLAR’S GENNAO H2TM SYSTEM

Apollon Solar is also active in hydrogen based clean renewable energy.  Over the years, they have developed an expertise in hydrogen production by hydrolysis, getting porous silicon nano powders to react with water “H2O” and therewith releasing significant quantities of hydrogen “H2”.

Drawing on this unique expertise, Apollon was approached by the French government to develop a compact and portable hydrogen-based electricity generation system that must be reliable and efficient enough to charge military personnel batteries on missions.  This work led to the creation of the Gennao H2TM a self-contained system that integrates a fuel cell.  The system operation is simple; a chemical powder is introduced, and as the powder reacts with water, hydrogen is generated by hydrolysis and converted into electricity by the integrated fuel cell, thus allowing the system to charge several batteries at once.

The operational capabilities of the system having reached the validation phase of the French military program, Apollon Solar is now ready to start the commercialization of a civilian version of its GennaoTM H2 system.

COLLABORATION WITH HPQ SILICON TO CREATE MORE EFFICIENT AND ECONOMICAL HYDROGEN

With Apollon Solar’s Hydrogen business having entered the commercial phase, HPQ took advantage of the 5th renewal to include it in the scope of the agreement.

Even though using porous silicon nanopowders would double the amount of hydrogen released by the system, the high costs of making porous silicon nanopowders required Apollon to use a less efficient, but more economical and environmentally friendly chemical powder to launch its GennaoTM H2 system.

With a goal of increasing the efficiency of the system, HPQ and Apollon will explore the technical and commercial potential of creating a new generation of more efficient, economical and environmentally friendly powders for the GennaoTM system using either:

  1. Silicon nanopowders made by HPQ’s PUREVAPTM Nano Silicon Reactor to increase the H2 generation potential of the GennaoTM H2 system by 40% (based on the mass capacity production of H2 of 14% of Silicon Nanopowders);
       a. By December 2020, HPQ-NANO plans to send Apollon the first samples of silicon nanopowders manufactured by PUREVAPTM NSiR for H2 generation testing;

  2. Porous silicon nanopowders manufactured with the transformation of Silicon produced by HPQ’s PUREVAPTM QRR process in Apollon’s patented process, to increase the H2 generation potential of the GennaoTM H2 system by 100% (based on the mass capacity production of H2 of 20% of Silicon Nanopowders);

Also included in the agreement is the right for HPQ to commercialize, exclusively in Canada, and non-exclusive in the U.S.A., the GennaoTM H2 system, as well as, also distribute and sell the powders required for the hydrolysis production of Hydrogen (“H2”).

Apollon will support HPQ North American marketing of the GennaoTM H2 system and the powder bags.  By November 2020, Apollon will make available to HPQ a GennaoTM H2 system and the bags of powder needed for demonstration to potential buyers.

During the term of this fifth renewal, Apollon and HPQ will work to finalize a long-term commercial agreement that will grant HPQ (or one of its subsidiaries) a Canadian exclusivity for the sale of GennaoTM H2 system and associated powders bags, and the exclusivity for all customers located in the United States to whom HPQ is marketing GennaoTM H2 system.

Finally, the parties have agreed that during the renewal period, or until the date of the signing of a long-term commercial agreement, that HPQ will have Canadian exclusivity on the distribution, sale, marketing and representation of GennaoTM H2 system and associated powders, and that it will be able to distribute, sell, market and represent GennaoTM H2 system and associated powders with customers in the United States.

About Silicon

Silicon (Si), also known as silicon metal, is one of today’s strategic materials needed to fulfil the Renewable Energy Revolution (“RER”) and the decarbonization of the economy presently under way.  Silicon does not exist in its pure state; it must be extracted from quartz (SiO2), in what has historically been a capital and energy intensive process.

About HPQ Silicon

HPQ Silicon Resources Inc. (TSX-V: HPQ) is a Canadian producer of Innovative Silicon Solutions, based in Montreal,  building a portfolio of unique high value specialty silicon products needed for the coming RER.

Working with PyroGenesis Canada Inc. (TSX-V: PYR), a high-tech company that designs, develops, manufactures and commercializes plasma – based processes, HPQ is developing:

  • The PUREVAPTM “Quartz Reduction Reactors” (QRR), an innovative process (patent pending), which will permit the one step transformation of quartz (SiO2) into high purity silicon (Si) at reduced costs, energy input, and carbon footprint that will propagate its considerable renewable energy potential;

    — HPQ believes it will become the lowest cost (Capex and Opex) producer of silicon (Si) and high purity silicon metal (3N – 4N Si);

  • The PUREVAPTM Nano Silicon Reactor (NSiR), a new proprietary process that can use different purities of silicon (Si) as feedstock, to make spherical silicon nanopowders and nanowires;

    — HPQ believes it can also become the lowest cost manufacturer of spherical Si nanopowders and silicon-based composites needed by manufacturers of next-generation lithium-ion batteries;

    — During the coming months, spherical Si nanopowders and nanowires silicon-based composite samples requested by industry participants and research institutions’ will be produced using PUREVAPTM SiNR.

HPQ is also working with industry leader Apollon Solar of France to:

  • Use their patented process and develop a capability to produce commercially porous silicon (Si) wafers and porous silicon (Si) powders;

    — The collaboration will allow HPQ to become the lowest cost producer of porous silicon wafers for all-solid -state batteries and porous silicon powders for Li-ion batteries;

    — Develop the hydrogen generation potential of Silicon nanopowders for usage with the GennaoTM system;

    — Commercialize, exclusively in Canada, and non-exclusive in the U.S.A., the GennaoTM H2 system and the chemical powders required for the hydrolysis production of Hydrogen (“H2”).

This News Release is available on the company’s CEO Verified Discussion Forum, a moderated social media platform that enables civilized discussion and Q&A between Management and Shareholders. 

Disclaimers:

The Corporation’s interest in developing the PUREVAP™ QRR and any projected capital or operating cost savings associated with its development should not be construed as being related to the establishing the economic viability or technical feasibility of any of the Company’s Quartz Projects.

This press release contains certain forward-looking statements, including, without limitation, statements containing the words “may”, “plan”, “will”, “estimate”, “continue”, “anticipate”, “intend”, “expect”, “in the process” and other similar expressions which constitute “forward-looking information” within the meaning of applicable securities laws. Forward-looking statements reflect the Company’s current expectation and assumptions and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those anticipated. These forward-looking statements involve risks and uncertainties including, but not limited to, our expectations regarding the acceptance of our products by the market, our strategy to develop new products and enhance the capabilities of existing products, our strategy with respect to research and development, the impact of competitive products and pricing, new product development, and uncertainties related to the regulatory approval process. Such statements reflect the current views of the Company with respect to future events and are subject to certain risks and uncertainties and other risks detailed from time-to-time in the Company’s on-going filings with the security’s regulatory authorities, which filings can be found at www.sedar.com. Actual results, events, and performance may differ materially. Readers are cautioned not to place undue reliance on these forward-looking statements. The Company undertakes no obligation to publicly update or revise any forward-looking statements either as a result of new information, future events or otherwise, except as required by applicable securities laws.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

For further information contact

Bernard J. Tourillon, Chairman, President and CEO Tel (514) 907-1011
Patrick Levasseur, Vice-President and COO Tel: (514) 262-9239
http://www.hpqsilicon.com Email: [email protected]